综合性多组学完善甲状腺癌的分子亚型,提高癌症进展预测:一项回顾性队列研究
Yoo Hyung Kim1, Joseph Wang2, Jae-Kyung Won3
1Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.
International journal of surgery (London, England)
|February 23, 2026
概括
一个新的NPF基因组改进了甲状腺癌 (TC) 的分类,提高了诊断准确度和预测疾病进展. 这种多主题的方法增强了个性化TC管理的风险分层.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 蛋白质组学是指蛋白质组学.
背景情况:
- 目前的甲状腺癌 (TC) 分子分类模型在区分毛囊模式瘤与正常甲状腺 (NT) 组织方面的有效性有限,并且缺乏对疾病进展的预测能力.
- 这项研究旨在完善TC分类,并开发瘤进展的预测系统.
研究的目的:
- 通过使用新型基因组来完善甲状腺癌 (TC) 的分类.
- 开发TC中瘤进展的预测系统.
- 提高诊断准确度和风险分层,以实现个性化的TC管理.
主要方法:
- 综合人类组织的转录组学 (SNUH-mRNASeq) 和蛋白质组学 (SNUH-TMT-Pro) 的多组学分析.
- 识别一种新型基因组,称为NPF基因,用于分类和风险分层.
- 通过免疫组织化学 (SNUH-IHC) 和外部数据集 (TCGA-THCA,SNUH-DIA-Pro,CellDis-Pro) 验证蛋白质标记物.
主要成果:
- NPF基因集群分离了带有BRAFV600E突变 (PTC-B),卵泡甲状腺癌 (FTC) 和NT的乳头甲状腺癌 (PTC),并将其分为不同的亚型 (BRAFV600E类,RAS类,NT类).
- 使用NPF基因的决策树分类模型实现了高精度 (0.92) 和卡帕统计 (0.88).
- 三种蛋白质生物标志物 (MATN2,FN1,PLSCR4) 证实了分子亚型,较高的NP/NF分数预测了特定TC亚型的更差预后.
结论:
- NPF基因组和分类模型显著改进了TC分类,提高了诊断准确度.
- 这些进展使得风险分层更好,为TC管理中的个性化治疗策略铺平了道路.
- 这项研究为改善甲状腺癌的临床决策提供了基础.
相关概念视频
02:07Tumor Progression
7.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.5K
02:50Combination Therapies and Personalized Medicine
6.2K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K